SCHEDULE 13G/A: Anson Funds Discloses 4.8% Stake in Meihua International Medical Technologies
Beneficial Ownership Statement
Anson Funds Management LP and its affiliates have disclosed a 4.8% beneficial ownership stake in Meihua International Medical Technologies Co., Ltd., as of December 31, 2024.
Summary
- Anson Funds Management LP, along with Anson Management GP LLC, Mr. Tony Moore, Anson Advisors Inc., Mr. Amin Nathoo, and Mr. Moez Kassam, collectively reported beneficial ownership of 1,205,255 Ordinary Shares of Meihua International Medical Technologies Co., Ltd.
- This ownership represents 4.8% of the company's outstanding Ordinary Shares.
- The percentage is calculated based on 23,940,000 shares issued and outstanding as of April 24, 2024 (per the Issuer's Form 20-F), plus 1,205,255 shares receivable upon the exercise of outstanding warrants held by the reporting persons, totaling 25,145,255 shares.
- The reporting persons, including Anson Funds Management LP and Anson Advisors Inc. as co-investment advisors, and their principals/directors, share voting and dispositive power over all 1,205,255 shares.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a passive investment intent, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by an investment fund, indicating a significant, but passive, stake in a publicly traded medical technology company. Such disclosures are common in the investment industry and provide transparency regarding major shareholder positions.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires the filing of this statement, representing the beneficial ownership position. |
| 02/14/2025 | Signature date of the Schedule 13G filing by all reporting persons. |
Keywords
Meihua International Medical Technologies, Anson Funds Management, Schedule 13G, Beneficial Ownership, SEC Filing, Ordinary Shares, Investment Management, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.